Chem-Labs is the exclusive distributor of IMMY products.
Known for its value-added distribution, Chem-Labs is the sole distributor of Immuno-Mycologics(IMMY), Inc products among them the Cryptoccoccus Lateral Flow Assay CrAg(LFA).
CrAg Lateral Flow Assay is the first and only dipstick test for the detection of cryptococcal antigen. Recently the World Health Organization released Rapid Advice (December 2011 issue) on Diagnosis, prevention and management of cryptococcal disease in HIV-infected Adults, Adolescents and Children where it recommended the use of CrAg LFA for diagnosis of cryptococcal diseases.
The recommendations at a glance contained in this Rapid Advice on diagnosis, prevention and management of cryptococcal disease (meningeal and non-meningeal) in adults, adolescents, and children are based on several guiding principles:
- Early diagnosis is key to improving mortality due to cryptococcal disease. Health care professionals need to have a low threshold for suspecting cryptococcal meningitis. Countries should prioritise reliable access to rapid diagnostic CrAg assays, either latex agglutination (LA) or lateral flow assay (LFA) for use in cerebrospinal fluid (CSF) and serum or plasma.
- Early ART initiation is the most important and cost-effective preventive strategy to reduce the incidence and high mortality associated with cryptococcal meningitis. Patients should ideally initiate ART at a CD4 count of 350 cells/mm3, and definitely before a decline in the CD4 cell count to less than 200 cells/mm 3, or development of WHO stage 3 or 4 disease.
- To promote the use of optimal antifungal treatment regimens and approaches that improve survival, clinical and neurological outcomes, and rapid fungal clearance, while minimising drug related toxicities.
- Prompt referral for HIV testing and care should be undertaken as soon as appropriate following diagnosis of cryptococcal disease, to facilitate early HIV diagnosis, uptake of ART and retention in care.
To read more about the report on Immy's website click here
or the document on WHO's website click here